Chronic fatigue syndrome: a hormonal origin? A rare case of dysmenorrhea membranacea.
Veldman, Joan, Van Houdenhove, Boudewijn, Verguts, Jasper · Archives of gynecology and obstetrics · 2009 · DOI
Quick Summary
This case describes a woman with chronic fatigue syndrome who developed a rare condition called membranous dysmenorrhea (where the uterine lining sheds in one piece) after starting a hormonal birth control pill. Interestingly, when she stopped the medication and the tissue was expelled, her fatigue symptoms completely disappeared and she was able to return to work. While this is just one patient's experience, it raises the possibility that hormone imbalances might contribute to chronic fatigue in some cases.
Why It Matters
This case is significant because it presents the first documented association between membranous dysmenorrhea and CFS resolution, offering preliminary evidence that hormonal dysregulation may be a contributing factor in at least a subset of ME/CFS patients. This observation could encourage further investigation into sex hormone pathophysiology in ME/CFS, particularly in women, and may inform treatment considerations for CFS patients with concurrent gynecological symptoms.
Observed Findings
A 44-year-old woman with pre-existing chronic fatigue syndrome developed membranous dysmenorrhea after 3 months of continuous oral contraceptive use.
Upon discontinuation of the oral contraceptive, normal menstruation resumed.
Complete disappearance of chronic fatigue syndrome symptoms occurred following expulsion of the endometrial tissue.
The patient returned to full work capacity after symptom resolution.
Membranous dysmenorrhea has been associated with elevated progesterone levels.
Inferred Conclusions
Hormonal dysfunction may be a possible etiopathogenic factor in chronic fatigue syndrome in some cases.
The relationship between membranous dysmenorrhea, progesterone dysregulation, and CFS warrants further systematic investigation.
Hormonal-based interventions merit consideration in CFS management, particularly when gynecological comorbidities are present.
Remaining Questions
What specific hormonal abnormalities (if any) were present in this patient, and how do they relate to CFS pathophysiology?
Could similar hormonal mechanisms explain CFS in other patients, or was this an isolated case with unique characteristics?
What This Study Does Not Prove
This single case report cannot establish causation or prove that hormonal dysfunction is a primary cause of ME/CFS in the general population. The temporal relationship between medication discontinuation and symptom resolution does not rule out placebo effect, natural disease course fluctuation, or other concurrent interventions. Findings from one patient cannot be generalized to other ME/CFS patients, the majority of whom may not have membranous dysmenorrhea or obvious hormonal abnormalities.
Tags
Symptom:Fatigue
Biomarker:Blood Biomarker
Method Flag:PEM Not DefinedWeak Case DefinitionNo ControlsSmall SampleExploratory Only